Inhibitory effect of green tea catechins on cysteine proteinases in Porphyromonas gingivalis

Oral Microbiology and Immunology

Volumn 19, Issue 2, 2004, Pages 118-120

  Okamoto, Masaaki ^a   Sugimoto, A ^b   Leung, K P ^c   Nakayama, K ^d   Kamaguchi, A ^e   Maeda, N ^a  

^a TSURUMI UNIVERSITY   (Japan)

^b 421 0516   (Japan)

^c US Army Dental and Trauma Research Detachment   (United States)

^d NAGASAKI UNIVERSITY   (Japan)

^e HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Catechin; Kgp; Porphyromonas gingivalis; Rgp

Indexed keywords

CATECHIN; CATECHIN GALLATE; CYSTEINE PROTEINASE; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; GALLOCATECHIN GALLATE; GINGIPAIN K; GINGIPAIN R; UNCLASSIFIED DRUG;

ARTICLE; DRUG EFFECT; ENZYME INHIBITION; IC 50; NONHUMAN; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; TEA;

ADHESINS, BACTERIAL; CATECHIN; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; HEMAGGLUTININS; HUMANS; PLANT EXTRACTS; PORPHYROMONAS GINGIVALIS; TEA;

EID: 1442289443     PISSN: 09020055     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0902-0055.2003.00112.x     Document Type: Article

References (29)

1. Abe N, Kadowaki T, Okamoto K, et al. Biochemical and functional properties of lysine-specific cysteine proteinase (Lysgingipain) as a virulence factor of Porphyromonas gingivalis in periodontal disease. J Biochem (Tokyo) 1998: 123: 305-312.
2. Curtis MA, Aduse-Opoku J, Rangarajan M. Cysteine proteases of Porphyromonas gingivalis. Crit Rev Oral Biol Med 2001: 12: 192-216.
3. Genco CA, Potempa J, Mikolajczyk-Pawlinska J, Travis J. Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease. Clin Infect Dis 1999: 28: 456-465.
4. Gibson FCr, Genco CA. Prevention of Porphyromonas gingivalis-induced oral bone loss following immunization with gingipain R1. Infect Immun 2001: 69: 7959-7963.
5. Grenier D, Plamondon P, Sorsa T, et al. Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives. J Periodontol 2002: 73: 79-85.
6. Holt SC, Kesavalu L, Walker S, Genco CA. Virulence factors of Porphyromonas gingivalis. Periodontol 2000 1999: 20: 168-238.
7. Houle MA, Grenier D, Plamondon P, Nakayama K. The collagenase activity of Porphyromonas gingivalis is due to Arg-gingipain. FEMS Microbiol Lett 2003: 221: 181-185.
8. Ikigai H, Nakae T, Hara Y, Shimamura T. Bactericidal catechins damage the lipid bilayer. Biochim. Biophys. Acta 1993: 1147: 132-136.
9. Imamura T. The role of gingipains in the pathogenesis of periodontal disease. J Periodontol 2003: 74: 111-118.
10. Imamura T, Matsushita K, Travis J, Potempa J. Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues. Antimicrob Agents Chemother 2001: 45: 2871-2876.
11. Kadowaki T, Yoneda M, Okamoto K, Maeda K, Yamamoto K. Purification and characterization of a novel arginine-specific cysteine proteinase (argingipain) involved in the pathogenesis of periodontal disease from the culture supernatant of Porphyromonas gingivalis. J Biol Chem 1994: 269: 21371-21378.
12. Kadowaki T, Nakayama K, Okamoto K, et al. Porphyromonas gingivalis proteinases as virulence determinants in progression of periodontal diseases. J Biochem (Tokyo) 2000: 128: 153-159.
13. Kitano S, Irimura K, Sasaki T, et al. Suppression of gingival inflammation induced by Porphyromonas gingivalis in rats by leupeptin. Jpn J Pharmacol 2001: 85: 84-91.
14. Kuboniwa M, Amano A, Shizukuishi S, Nakagawa I, Hamada S. Specific antibodies to Porphyromonas gingivalis Lys-gingipain by DNA vaccination inhibit bacterial binding to hemoglobin and protect mice from infection. Infect Immun 2001: 69: 2972-2979.
15. Kuramitsu HK. Proteases of Porphyromonas gingivalis: what don't they do? Oral Microbiol Immunol 1998: 13: 263-270.
16. Lamont RJ, Jenkinson HF. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev 1998: 62: 1244-1263.
17. Mabe K, Yamada M, Oguni I, Takahashi T. In vitro and in vivo activities of tea catechins against Helicobacter pylori. Antimicrob Agents Chemother 1999: 43: 1788-1791.
18. Moritz AJ, Cappelli D, Lantz MS, Holt SC, Ebersole JL. Immunization with Porphyromonas gingivalis cysteine protease: effects on experimental gingivitis and ligature-induced periodontitis in Macaca fascicularis. J Periodontol 1998: 69: 686-697.
19. Nakagawa T, Sims T, Fan Q, et al. Functional characteristics of antibodies induced by Arg-gingipain (HRgpA) and Lys-gingipain (Kgp) from Porphyromonas gingivalis. Oral Microbiol Immunol 2001: 16: 202-211.
20. O'Brien-Simpson NM, Paolini RA, Hoffmann B, et al. Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model. Infect Immun 2001: 69: 7527-7534.
21. Okamoto M, Takano K, Maeda N. Distribution of the tetracycline resistance determinant tetQ gene in oral isolates of black-pigmented anaerobes in Japan. Oral Microbiol Immunol 2001: 16: 224-228.
22. Okamoto M, Leung KP, Ansai T, Sugimoto A, Maeda N. Inhibitory effects of green tea catechins on protein tyrosine phosphatase in Prevotella intermedia. Oral Microbiol Immunol 2003: 18: 192-195.
23. Sakanaka S, Aizawa M, Kim M, Yamamoto T. Inhibitory effects of green tea polyphenols on growth and cellular adherence of an oral bacterium, Porphyromonas gingivalis. Biosci Biotechnol Biochem 1996: 60: 745-749.
24. Shi Y, Ratnayake DB, Okamoto K, et al. Genetic analyses of proteolysis, hemoglobin binding, and hemagglutination of Porphyromonas gingivalis. Construction of mutants with a combination of rgpA, rgpB, kgp, and hagA. J Biol Chem 1999: 274: 17955-17960.
25. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL, Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998: 25: 134-144.
26. Sugita-Konishi Y, Hara-Kudo Y, Amano F, et al. Epigallocatechin gallate and gallocatechin gallate in green tea catechins inhibit extracellular release of Vero toxin from enterohemorrhagic Escherichia coli 0157:H7. Biochim Biophys Acta 1999: 1472: 42-50.
27. Travis J, Pike R, Imamura T, Potempa J. Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis. J Periodontal Res 1997: 32: 120-125.
28. Yonezawa H, Ishihara K, Okuda K. Arg-gingipain a DNA vaccine induces protective immunity against infection by Porphyromonas gingivalis in a murine model. Infect Immun 2001: 69: 2858-2864.
29. Zhao WH, Hu ZQ, Okubo S, Hara Y, Shimamura T. Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2001: 45: 1737-1742.